Weight loss drugs like Wegovy and Zepbound aren't just making people lighter — they're also changing how people shop.

A new analysis of consumer behavior from PwC, published in the Harvard Business Review, suggests the GLP-1 medications are leading people to spend less on groceries and to choose healthier options.

Looking at more than 11,000 U.S. households, the analysis found that grocery spending declined 6% to 8% within the first year where a GLP-1 user was the primary food purchaser.

RELATED STORY | Eli Lilly could bring first widely available GLP‑1 pill for obesity, diabetes to market this year

Outside the grocery store, people are spending less on fast food but spending more on full service restaurants.

Consumers are also buying more clothes. Some of that is to replace clothe

See Full Page